Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
Huashan Hospital
Huashan Hospital
M.D. Anderson Cancer Center
Institut Pasteur du Cambodge
Children's Hospital Medical Center, Cincinnati
Children's Hospital Medical Center, Cincinnati
TILT Biotherapeutics Ltd.
Stanford University
Baylor College of Medicine
Columbia University
University Hospital Freiburg
Columbia University
Beijing Neurosurgical Institute
EpicentRx, Inc.